PHI with Basilar artery thrombosis
How does this condition affect your private health insurance?
Basilar Artery Thrombosis is a critical medical emergency caused by a blood clot obstructing the basilar artery, vital for brainstem and cerebellum blood supply. This blockage severely impairs essential functions like consciousness, breathing, and motor control. Symptoms include sudden vertigo, headache, double vision, slurred speech, and bilateral weakness. Without immediate intervention, it can cause devastating neurological deficits, locked-in syndrome, or death. Prompt diagnosis, typically via MRI or CT angiography, and urgent revascularization therapy, such as intravenous thrombolysis or endovascular thrombectomy, are crucial for survival and minimizing disability. Recovery frequently necessitates extensive rehabilitation.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 50%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute phase typically lasts hours to days, with hospital stay ranging from days to weeks, often in intensive care.
Duration of Illness (Lifetime)
One-time acute event, but often leads to chronic neurological deficits requiring lifelong management and rehabilitation.
Cost of Treatment (Initial)
High, estimated $50,000 - $300,000 USD, depending on the need for intensive care, advanced imaging, thrombolysis, or endovascular thrombectomy.
Cost of Treatment (Lifetime)
Potentially hundreds of thousands to millions of USD for long-term rehabilitation, medications, and ongoing care for chronic neurological deficits.
Mortality Rate
High (20-50% even with modern treatment; significantly higher without immediate intervention).
Risk of Secondary Damages
Very high (70-90% for significant neurological deficits such as locked-in syndrome, severe motor or cognitive impairments, or dysphagia).
Probability of Full Recovery
Low (<10-20% for full functional recovery without significant residual deficits).
Underlying Disease Risk
High probability of underlying cardiovascular risk factors including atherosclerosis, hypertension, diabetes, hyperlipidemia, atrial fibrillation, or other prothrombotic conditions.